FIXTURESNo upcoming fixtures — check back soon.
FORUM / MIKES GRIPES /  Merck Asks FDA For Emergency Use Authorization For Its $700 COVID Pill, Biden Already Bought 1.7 Million

Merck Asks FDA For Emergency Use Authorization For Its $700 COVID Pill, Biden Already Bought 1.7 Million

Started by Beeno13 REPLIES1,665 VIEWS· 13 Oct 2021, 14:35
SHAREXFACEBOOKWHATSAPPTELEGRAMREDDITLINKEDIN
BE
Beeno1Captain40,032 posts
13 Oct 2021, 14:35
#1
13 Oct 2021, 14:35#1

I posted a clip about how the Merck dreug causes cancer and infertility. Best you read it.

Biden spends over $2.4 billion on Merck wonder drug so good it deserves a 4,000% markup

Yesterday the pharmaceutical giant Merck asked the Food and Drug Administration to grant emergency use authorization for its new pill, Malnupiravir, that can treat COVID-19 for the eye watering price of $712, and Joe Biden already bought 1.7 million. The drug costs Merck $17.74 to produce.

“Merck said it is asking for authorization for the capsules to treat infected adults who are at risk of progressing to severe Covid-19 disease or hospitalization,” reported CNN. A drug trial for Malnupiravir was reportedly ended early “because the drug was working so well” versus the placebo. “Data from this trial has not yet been peer-reviewed or published,” CNN later noted.

The left wing news outlet also notes that Merck, like Pfizer with its COVID-19 pill, has been producing the drug in large numbers even before studies could be completed or the FDA granted it some form of clearance to enter the market. The company “expects to produce 10 million courses of treatment by the end of 2021,” wrote CNN. “It has already sold 1.7 million treatment courses to the US government.”

It is unclear how many pills are needed per “course of treatment,” but only assuming two pills, the cost to taxpayers is already over $2.4 billion. Most of this is profit to Merck, which sells its pill at a 4,000% markup, as National File recently reported:

Merck, likely looking at competitors Pfizer and Moderna who have made extreme profits selling vaccines during the pandemic, apparently realized this was an opportunity to expand their profits and decided to charge the government $712 for the same amount of medicine. This is nearly a 3913.53% increase from the cost to produce the supposed miracle drug.

The Intercept notes that “the pill could bring staggering profits to both Merck and Ridgeback Biotherapeutics.” Ridgeback is apparently a “small Miami-based company,” that actually “licensed the medicine from Emory University in 2020 and two months later sold the worldwide rights to the drug to Merck for an undisclosed sum.” The company has been accused of “flipping” the drug for a profit.

COVID-19 profits seem to be the guiding factor for some pharmaceutical companies. Moderna, a small and mostly unsuccessful company prior to the pandemic, had already made $12 billion in August of this year, and one of the Pfizer scientists caught on video speaking with Project Veritas revealed his company was now completely dependent on “COVID money.”

Don' t believe anything Mozzzzz says about Covid. I suspect Mozzzz has millions invested in Big Pharma. Imagine trying to tell us Big Pharma is making nothing much from these deadly products!

MO
MozartCaptain49,914 posts
14 Oct 2021, 05:53
#2
14 Oct 2021, 05:53#2

So on November the 30th 2018, long before Covid,  Pfizer’s stock price was $43.8….today it closed at $41.4. Why? Because the markets view vaccine profits as short term and unsustainable.

An established drug company like Pfizer would not jeopardize it’s brand for this ‘sugar lift’ unless it was totally confident in the vaccine.


Other drug companies like Johnson and Johnson and AstraZeneca are not taking any profits on their vaccines.


So much for the greedy drug companies making money at the expense of safety.  


PL
PlumCaptain21,007 posts
14 Oct 2021, 07:55
#3
14 Oct 2021, 07:55#3
PL
PlumCaptain21,007 posts
14 Oct 2021, 08:09
#4
14 Oct 2021, 08:09#4
15 October 2018 close was 36.51…so it’s up by about 4.89 over two years. Not bad actually. I suspect that when we look again at the close in November, it should up a few more %. I only post this because historically the worst month for stocks is September with this year’s having been pretty bad. https://moneymorning.com/2013/09/04/why-stocks-fall-in-september/ …and the best recoveries usually occur November through December. So it seems reasonable to compare closing months directly as opposed to an October vs a November.
— END OF THREAD —

More from Mikes Gripes